Literature DB >> 15621755

Aggressive Natural Killer-Cell Leukemia: report of five cases and review of the literature.

Anna Ruskova1, Rekha Thula, George Chan.   

Abstract

We report 5 cases of Aggressive Natural Killer-Cell Leukemia (ANKL) diagnosed and treated in our institution within a period of 5 years. Presented are the clinical, hematological, immunophenotypic, immunogenotypic and cytogenetic data. ANKL is a very rare disorder. On review of the English-language literature only 68 published cases were identified. Analysis was performed on a total number of 73 cases (68 from the literature and the series of 5 presented hereby). Presented and discussed are the epidemiology, clinical picture, morphology, cell marker, immunogenotype, cytogenetics, and survival data of the analysis, as well as the associations with the Epstein-Barr virus (EBV). To our knowledge this is the largest series of cases of ANKL analyzed and therefore it is hoped to contribute towards a better characterization of the disorder.

Entities:  

Mesh:

Year:  2004        PMID: 15621755     DOI: 10.1080/10428190400004513

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  22 in total

1.  Natural killer cell leukaemia.

Authors:  Jamish Gandhi
Journal:  BMJ Case Rep       Date:  2009-09-01

Review 2.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

3.  Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.

Authors:  Fumihiro Ishida; Young Hyeh Ko; Won Seog Kim; Junji Suzumiya; Yasushi Isobe; Kazuo Oshimi; Shigeo Nakamura; Ritsuro Suzuki
Journal:  Cancer Sci       Date:  2012-03-23       Impact factor: 6.716

4.  EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.

Authors:  Alina Nicolae; Karthik A Ganapathi; Trinh Hoc-Tran Pham; Liqiang Xi; Carlos A Torres-Cabala; Nahid M Nanaji; Hongbin D Zha; Zhen Fan; Sybil Irwin; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

5.  Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis.

Authors:  Mehdi Hamadani; Abraham S Kanate; Alyssa DiGilio; Kwang Woo Ahn; Sonali M Smith; Jong Wook Lee; Ernesto Ayala; Nelson Chao; Parameswaran Hari; Javier Bolaños-Meade; Ronald Gress; Niels Smedegaard Anderson; Yi-Bin Chen; Umar Farooq; Gary Schiller; Jean Yared; Anna Sureda; Timothy S Fenske; Horatiu Olteanu
Journal:  Biol Blood Marrow Transplant       Date:  2017-02-01       Impact factor: 5.742

6.  EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.

Authors:  Juehua Gao; Amir Behdad; Peng Ji; Kristy L Wolniak; Olga Frankfurt; Yi-Hua Chen
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

7.  A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Mutsumi Wakabayashi; Hidenori Imai; Yasunobu Sekiguchi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ota; Kengo Takeuchi; Yoshinori Ito; Hiroshi Kimura; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

8.  Six cases of aggressive natural killer-cell leukemia in a Chinese population.

Authors:  Qiguo Zhang; Wang Jing; Jian Ouyang; Hui Zeng; Suraj K George; Zhiqiang Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

9.  Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.

Authors:  Jeong A Park; Kyung Ran Jun; So Hyun Nam; Thad T Ghim
Journal:  Int J Hematol       Date:  2013-04-04       Impact factor: 2.490

Review 10.  The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.

Authors:  A A Gru; B H Haverkos; A G Freud; J Hastings; N B Nowacki; C Barrionuevo; C E Vigil; R Rochford; Y Natkunam; R A Baiocchi; P Porcu
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.